Therapeutic Agents definition

Therapeutic Agents as used in these rules means any agent approved by the United States Food and Drug Administration (FDA) for use in controlled drug delivery systems in the course of periodontal pocket treatment.
View Source
Therapeutic Agents as used herein, means Licensed Products which are in a final formulation, irrespective of concentration or packaging, which could be administered to a patient for therapy.
View Source

Examples of Therapeutic Agents in a sentence

  • Your Final Award of RSUs will vest on the ____________________________________________________ (the “Vesting Period”).

  • RapidTox Service consists of RapidTox Panel I (Drugs of Abuse and Alcohol Panel), and RapidTox Panel II (Therapeutic Agents, Drugs of Abuse and Alcohol Panel).

  • LLNL and Trius jointly responded to a U.S. Health and Human Services (National Institutes of Health) request for proposals (solicitation # BAA NIH-NIAID-DMID 08-20) to develop new therapeutic countermeasures with a proposal entitled “Development of Therapeutic Agents for Select Biodefense Pathogens” which resulted in this CRADA, with a goal of developing gram-negative, dual-target antibacterial agents that show no cross-resistance to existing drugs.

  • Section 7.1 During the Research Term Section 7.2 During the Term Section 7.3 Exceptions Section 7.4 Protected Therapeutic Agents.

  • UBC INEX [***]% [***]% [***]% ▇▇▇-2700-IE Methods for Preparation of Lipid-Encapsulated Therapeutic Agents Irish Patent No. IE 1194122 GRANTED ▇▇▇▇▇▇, ▇.

  • UBC INEX [***]% [***]% [***]% ▇▇▇-2700-ES Methods for Preparation of Lipid-Encapsulated Therapeutic Agents Spanish Patent No. ES 1194122 GRANTED ▇▇▇▇▇▇, ▇.

  • For Therapeutic Agents which are Non-Patent Products and contain an Antibody Conjugate, the calculated royalty rate shall equal one and three-quarters percent (1.75%) times the Cost of the Hybridoma divided by the Cost of the Final Product; provided, however, the immediately-above calculated royalty rate shall in no event be less than one and one-quarter percent (1.25%).

  • UBC INEX [***]% [***]% [***]% ▇▇▇-2700-US Methods for Preparation of Lipid-Encapsulated Therapeutic Agents U.S. Patent Application No. 10/019,199 PENDING ▇▇▇▇▇▇, ▇.

  • UBC INEX [***]% [***]% [***]% ▇▇▇-2700-IS Methods for Preparation of Lipid-Encapsulated Therapeutic Agents Icelandic Patent Application No. PCT/CA00/00843 ABANDONED - OCTOBER 19, 2004 ▇▇▇▇▇▇, ▇.

  • UBC INEX [***]% [***]% [***]% ▇▇▇-2700-CA Methods for Preparation of Lipid-Encapsulated Therapeutic Agents Canadian Patent Application No. 2,378,438 PENDING Maurer, ▇.